Your browser doesn't support javascript.
loading
Phase I study of BNC105P, carboplatin and gemcitabine in partially platinum-sensitive ovarian cancer patients in first or second relapse (ANZGOG-1103).
Lindemann, Kristina; Beale, Philip J; Rossi, Emma; Goh, Jeff C; Vaughan, Michelle M; Tenney, Meaghan E; Martyn, Julie K; Sommeijer, Dirkje; Iglesias, Jose L; Kremmidiotis, Gabriel; Simpson, Jeremy; Doolin, Elizabeth; Lavranos, Tina C; Leske, Annabell; Veillard, Anneso S; Espinoza, David; Stockler, Martin R; Rischin, Danny.
Afiliação
  • Lindemann K; NHMRC Clinical Trials Centre, Sydney, Australia.
  • Beale PJ; Division of Medicine, Department of Gynaecological Oncology, Oslo University Hospital, Oslo, Norway.
  • Rossi E; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
  • Goh JC; Chris O'Brien Lifehouse, Sydney, NSW, Australia.
  • Vaughan MM; Gynecologic Oncology, Department of Obstetrics and Gynecology, University of North Carolina, Chapel Hill, USA.
  • Tenney ME; Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia.
  • Martyn JK; Christchurch Hospital, Christchurch, New Zealand.
  • Sommeijer D; Northside Hospital, University Gynecologic Oncology, Sandy Springs, USA.
  • Iglesias JL; University of Chicago Medicine, Chicago, IL, USA.
  • Kremmidiotis G; NHMRC Clinical Trials Centre, Sydney, Australia.
  • Simpson J; Academic Medical Centre, Amsterdam, The Netherlands.
  • Doolin E; Flevohospital, Almere, The Netherlands.
  • Lavranos TC; Apobiologix, Toronto, ON, M9L2Y6, Canada.
  • Leske A; Bionomics Ltd, Thebarton, SA, Australia.
  • Veillard AS; Bionomics Ltd, Thebarton, SA, Australia.
  • Espinoza D; Bionomics Ltd, Thebarton, SA, Australia.
  • Stockler MR; Bionomics Ltd, Thebarton, SA, Australia.
  • Rischin D; Bionomics Ltd, Thebarton, SA, Australia.
Cancer Chemother Pharmacol ; 83(1): 97-105, 2019 01.
Article em En | MEDLINE | ID: mdl-30368585

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias do Endométrio / Cistadenocarcinoma Seroso / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Cancer Chemother Pharmacol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Austrália

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias do Endométrio / Cistadenocarcinoma Seroso / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Cancer Chemother Pharmacol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Austrália